Skip to main content
. 2021 May 17;13(5):1697. doi: 10.3390/nu13051697

Table 2.

Coenzyme Q10 and migraine.

Study Design Daily Doses Effects on Symptoms Effects on Lab. or Instrumental
Parameters
Effects on Hard Outcomes
Migraine RCTs 100–400 mg/day ↓ duration and severity of attacks ↓ TNFα and GCPR levels Not investigated

↓ = it is indicative of a reduction of a marker or a symptom.

HHS Vulnerability Disclosure